vancomycin has been researched along with Co-infection in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 16 (69.57) | 24.3611 |
| 2020's | 7 (30.43) | 2.80 |
| Authors | Studies |
|---|---|
| Das, S; Gunasekaran, R; Mitra, S; Mohamed, A; Prajna, L; Prajna, NV; Sharma, S; Soni, T | 1 |
| Belkaid, Y; Bending, D; Collins, N; Conlan, S; Deming, C; Desai, JV; Drummond, RA; Green, NM; Lecky, D; Lee, CR; Lionakis, MS; Matei-Rascu, V; Prevots, DR; Quinones, M; Ricotta, EE; Segre, JA; Sherif, L; Swamydas, M; Withers, D; Zelazny, AM | 1 |
| Abdulaziz, O; Al-Hazmi, A; Alenazi, M; Aljuaid, A; Allahyani, M; Almehmadi, M; Alosimi, E; Alsiwiehri, N; Halawi, M; Rebh, F; Turjoman, A | 1 |
| Bannan, A; Diab, J; Pollitt, T | 1 |
| Chhabria, M; Kudaravalli, P; Lesho, E; Pendela, VS | 1 |
| Busch, DH; Dommasch, M; Feihl, S; Heim, M; Lahmer, T; Lukas, M; Querbach, C; Rothe, K; Schmid, RM; Schneider, G; Schneider, J; Spinner, CD; Treiber, M; Wallnöfer, F; Waschulzik, B; Wurst, M; Zink, A | 1 |
| Aghajani, F; Akhavizadegan, H; Dolatkhani, F; Faghir Gangi, M; Ghasemi, H; Ghazi, Z; Mousavi Movahed, SM; Nejadghaderi, SA | 1 |
| Fleisher, J; Hamada, A; Hwang, C; Tuerk, I | 1 |
| Cairns, BA; Conlon, BP; Gode, CJ; Kartchner, LB; Lachiewicz, AM; Maile, R; Radlinski, L; Rowe, SE; Vitko, NP; Wolfgang, MC | 1 |
| Awais, R; Beenken, KE; Boles, LR; Haggard, WO; Jessica, AJ; Smeltzer, MS | 1 |
| Ackerman, KG; Bubeck Wardenburg, J; Cvijanovich, N; Gedeit, RG; Giuliano, JS; Hall, MW; Hartman, ME; Markovitz, B; Moffitt, KL; Newhams, MM; Novak, T; Randolph, AG; Sanders, RC; Shein, SL; Tarquinio, KM; Thomas, NJ; Truemper, EJ; Weiss, SL; Xu, R | 1 |
| Thomsen, IP | 1 |
| Chen, Z; Cheng, Y; Cui, G; Guan, Z; Hong, W; Huang, X; Liao, J; Qi, X; Rao, F; Wang, P; Wang, S; Wang, Y; Yang, J; Zhang, J | 1 |
| Ellis, DB; Weimer, JM | 1 |
| Fusco, DN; He, Y; Liu, X; Papanicolaou, GA; White, JR; Xiao, K | 1 |
| Cuervo, M; Delgado, T; Hernández-Porto, M; Lecuona, M; Miguel-Gómez, MA | 1 |
| Escosa-García, L; García-Gil, V; Gómez-Gil, MR; Hierro-Llanillo, L | 1 |
| Conejo, MC; Domínguez, MC; Pascual, Á; Rodríguez-Baño, J; Vergara-López, S | 1 |
| Carr, JP; Diamond, Y; Freyne, B; Gwee, A | 1 |
| Barriere, SL; Corey, GR; Hardin, TC; Lacy, MK; Luke, DR; Nogid, B; Shorr, AF; Stryjewski, ME; Wang, W | 1 |
| Carfagna, P; Falcone, M; Goldoni, P; Iraci, F; Russo, A; Venditti, M; Vullo, V | 1 |
| Aguirre Quiñonero, A; Angulo López, I; González Escartín, E; Ots Ruiz, E | 1 |
| Ahmed, F; Ajamoughli, M; Bathina, P; Hayakawa, K; Ho, K; Jagadeesh, KK; Kamatam, S; Kaye, KS; Khan, A; Lee, KP; Levine, M; Marchaim, D; Martin, ET; Moshos, JA; Mustapha, M; Omotola, AM; Patel, D; Pogue, JM; Reddy, SM; Rybak, MJ; Suhrawardy, U; Sunkara, B; Willis, LB | 1 |
1 trial(s) available for vancomycin and Co-infection
| Article | Year |
|---|---|
Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Coinfection; Cross Infection; Double-Blind Method; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospital Mortality; Humans; Lipoglycopeptides; Male; Middle Aged; Pneumonia, Ventilator-Associated; Time Factors; Treatment Outcome; Vancomycin; Young Adult | 2015 |
22 other study(ies) available for vancomycin and Co-infection
| Article | Year |
|---|---|
Corynebacterium Keratitis: Pure Versus Mixed Infection and Antibiotic Susceptibility Patterns From Different Tertiary Eye Care Centers.
Topics: Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Coinfection; Corynebacterium; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Keratitis; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Retrospective Studies; Tertiary Care Centers; Vancomycin | 2022 |
Long-term antibiotic exposure promotes mortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteria.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Candida albicans; Candidiasis, Invasive; Coinfection; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Iatrogenic Disease; Immunotherapy; Interleukin-17; Mice; Th17 Cells; Vancomycin | 2022 |
Evaluation of Renal Function in COVID-19 Patients by Using Urinalysis Following the Administration of Vancomycin.
Topics: Coinfection; COVID-19; Female; Glycosuria; Hematuria; Humans; Ketosis; Kidney; Male; Prediabetic State; Proteinuria; Retrospective Studies; Urinalysis; Vancomycin | 2022 |
Necrotising fasciitis.
Topics: Abdomen; Adult; Anti-Bacterial Agents; Clindamycin; Coinfection; Debridement; Diabetes Mellitus, Type 2; Fasciitis, Necrotizing; Female; Fluid Therapy; Humans; Meropenem; Methicillin-Resistant Staphylococcus aureus; Obesity; Renal Insufficiency, Chronic; Resuscitation; Staphylococcal Infections; Streptococcal Infections; Streptococcus pyogenes; Vancomycin | 2020 |
Case Report: A Polymicrobial Vision-Threatening Eye Infection Associated with Polysubstance Abuse.
Topics: Administration, Ophthalmic; Adult; Anti-Inflammatory Agents; Antioxidants; Ascorbic Acid; Ceftazidime; Cocaine; Cocaine-Related Disorders; Coinfection; Dopamine Uptake Inhibitors; Doxycycline; Endophthalmitis; Female; Gram-Positive Bacterial Infections; Humans; Keratitis; Kingella; Linezolid; Moxifloxacin; Neisseriaceae Infections; Ophthalmic Solutions; Prednisone; Propionibacterium acnes; Streptococcal Infections; Streptococcus; Substance Abuse, Intravenous; Tobramycin; Vancomycin; Voriconazole | 2020 |
Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Antifungal Agents; Antimicrobial Stewardship; Aspergillosis; Azithromycin; Bacterial Infections; Cohort Studies; Coinfection; COVID-19; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Germany; Humans; Klebsiella Infections; Linezolid; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Practice Patterns, Physicians'; Retrospective Studies; SARS-CoV-2; Staphylococcal Infections; Streptococcal Infections; Sulbactam; Vancomycin; Young Adult | 2021 |
Different incidences of acute kidney injury (AKI) and outcomes in COVID-19 patients with and without non-azithromycin antibiotics: A retrospective study.
Topics: Acute Kidney Injury; Adult; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azithromycin; Coinfection; COVID-19; COVID-19 Drug Treatment; Critical Care; Drug Combinations; Female; Hospital Mortality; Hospitalization; Humans; Iran; Linezolid; Lopinavir; Male; Middle Aged; Retrospective Studies; Ribavirin; Ritonavir; SARS-CoV-2; Treatment Outcome; Vancomycin | 2021 |
Microbiological evaluation of infected pelvic lymphocele after robotic prostatectomy: potential predictors for culture positivity and selection of the best empirical antimicrobial therapy.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Coinfection; Cyst Fluid; Drug Therapy, Combination; Humans; Leukocytosis; Lymph Node Excision; Lymphocele; Male; Middle Aged; Pelvis; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Robotic Surgical Procedures; Staphylococcal Infections; Staphylococcus; Sulbactam; Vancomycin | 2017 |
Pseudomonas aeruginosa exoproducts determine antibiotic efficacy against Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Burns; Coinfection; Drug Resistance, Bacterial; Glycolipids; Mice; Mice, Inbred C57BL; Microbial Interactions; Microbial Sensitivity Tests; Microbial Viability; Oxygen Consumption; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Wound Infection | 2017 |
Local Delivery of Amikacin and Vancomycin from Chitosan Sponges Prevent Polymicrobial Implant-Associated Biofilm.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Biofilms; Chitosan; Coinfection; Disease Models, Animal; Mice; Microbial Sensitivity Tests; Vancomycin | 2018 |
Vancomycin Monotherapy May Be Insufficient to Treat Methicillin-resistant Staphylococcus aureus Coinfection in Children With Influenza-related Critical Illness.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Coinfection; Critical Illness; Female; Humans; Infant; Infant, Newborn; Influenza, Human; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Prospective Studies; Survival Analysis; Treatment Outcome; Vancomycin | 2019 |
The Concern for Vancomycin Failure in the Treatment of Pediatric Staphylococcus aureus Disease.
Topics: Child; Coinfection; Critical Illness; Humans; Influenza, Human; Methicillin; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2019 |
Co-infection of Clostridioides (Clostridium) difficile GMU1 and Bacillus cereus GMU2 in one patient in Guizhou, China.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Bacillus cereus; China; Clostridioides difficile; Coinfection; Genotype; Humans; Male; Vancomycin | 2018 |
Superbug Meets Opportunistic Infection: A Case Report of Mobilized Colistin Resistance-1-Positive Klebsiella pneumoniae and Candida lusitaniae in a Complex Surgical Patient.
Topics: Candidiasis, Invasive; Cilastatin, Imipenem Drug Combination; Coinfection; Drug Resistance, Multiple, Bacterial; Gastrointestinal Hemorrhage; Humans; Intestinal Fistula; Klebsiella Infections; Klebsiella pneumoniae; Male; Micafungin; Middle Aged; Pancreatitis, Acute Necrotizing; Treatment Outcome; Vancomycin | 2019 |
Effect of linezolid on clinical severity and pulmonary cytokines in a murine model of influenza A and Staphylococcus aureus coinfection.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Load; Coinfection; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Immunologic Factors; Influenza A virus; Influenza, Human; Interleukins; Linezolid; Lung; Mice; Mice, Inbred C57BL; Oxazolidinones; Severity of Illness Index; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Viral Load; Weight Loss | 2013 |
[Diabetic leg ulcer colonized by Bordetella trematum].
Topics: Achromobacter; Aged; Anti-Bacterial Agents; Bordetella; Ceftazidime; Coinfection; Corynebacterium Infections; Diabetic Foot; Female; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Wound Infection | 2013 |
Linezolid and vancomycin-resistant Enterococcus faecium peritonitis in a child after liver transplantation.
Topics: Biliary Atresia; Child, Preschool; Coinfection; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Liver Transplantation; Male; Peritonitis; Portoenterostomy, Hepatic; Postoperative Complications; Pseudomonas Infections; RNA, Bacterial; RNA, Ribosomal, 23S; Vancomycin | 2015 |
Prolonged treatment with large doses of fosfomycin plus vancomycin and amikacin in a case of bacteraemia due to methicillin-resistant Staphylococcus epidermidis and IMP-8 metallo-β-lactamase-producing Klebsiella oxytoca.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Coinfection; Fosfomycin; Humans; Klebsiella Infections; Klebsiella oxytoca; Male; Methicillin Resistance; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin | 2015 |
Brain Abscess Due to Staphylococcus lugdunenis: A CoNSiderable Pathogen.
Topics: Brain Abscess; Ceftriaxone; Cerebellum; Child, Preschool; Coinfection; Dermoid Cyst; Drainage; Female; Floxacillin; Humans; Magnetic Resonance Imaging; Staphylococcal Infections; Staphylococcus; Teicoplanin; Treatment Outcome; Vancomycin | 2015 |
Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection.
Topics: Aged; Anti-Infective Agents; Bacteremia; Candida; Candidiasis; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Coinfection; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Metronidazole; Multivariate Analysis; Odds Ratio; Risk Factors; Survival Analysis; Treatment Outcome; Vancomycin | 2016 |
[Simultaneous pneumococcal and enterovirus meningitis in an infant].
Topics: Anti-Bacterial Agents; Cefotaxime; Coinfection; Disease Outbreaks; Disease Susceptibility; Drug Therapy, Combination; Enterovirus Infections; Female; Humans; Infant; Magnetic Resonance Imaging; Meningitis, Pneumococcal; Meningitis, Viral; Seasons; Vancomycin | 2017 |
Independent risk factors for the co-colonization of vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant Staphylococcus aureus isolation.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Coinfection; Drug Resistance, Bacterial; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Odds Ratio; Retrospective Studies; Risk Factors; Staphylococcal Infections; Vancomycin | 2013 |